Large-scale testing (Phase 3)Ended earlyNCT03670901
What this trial is testing
Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
Who this might be right for
Diffuse Large B-Cell Lymphoma
JHL Biotech, Inc. 8